Company Description
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management.
It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem.
Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
| Country | United States |
| Founded | 2011 |
| IPO Date | Sep 15, 2021 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 830 |
| CEO | Jason Ronald Krantz |
Contact Details
Address: 492 Old Connecticut Path, Suite 401 Framingham, Massachusetts 01701 United States | |
| Phone | 508-720-4224 |
| Website | definitivehc.com |
Stock Details
| Ticker Symbol | DH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $27.00 |
| CIK Code | 0001861795 |
| CUSIP Number | 24477E103 |
| ISIN Number | US24477E1038 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Jason Ronald Krantz | Founder, Executive Chairman and Interim Chief Executive Officer |
| Jonathan Maack | President |
| Richard Douglas Booth | Chief Financial Officer |
| Kate Marie Shamsuddin Jensen | Chief Product Officer |
| Scott Oberlink | Chief Technology Officer |
| Matthew Ruderman | Chief Legal Officer and Secretary |
| Craig Hazenfield | Chief People Officer |
| Ram Sharma | Executive Vice President of Life Sciences |
| Carrie Lazorchak | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 7, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 7, 2024 | 10-Q | Quarterly Report |
| May 7, 2024 | 8-K | Current Report |
| Apr 9, 2024 | ARS | Filing |
| Apr 9, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |